Risk stratification biomarkers for Staphylococcus aureus bacteraemia
Abstract Objectives To identify risk stratification biomarkers to enrich for the subset of Staphylococcus aureus bacteraemia patients who develop deep‐seated tissue infections with high morbidity and mortality to guide clinical trial enrolment and clinical management. Methods We evaluated the progno...
Asıl Yazarlar: | , , , , , , , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Wiley
2020-01-01
|
Seri Bilgileri: | Clinical & Translational Immunology |
Konular: | |
Online Erişim: | https://doi.org/10.1002/cti2.1110 |